This course provides an update on newly approved topical medications for the treatment of glaucoma and ocular hypertension. Emphasis is placed on each drug’s indications, contraindications, adverse effects, efficacy, and cost.
Over 1800 attended our event and we received amazing feedback!
Feedback from anonymous survey:
Thank you for an excellent very informative webinar, this was one of the BEST webinars I have seen!
Good explanation of side effects. With that and the cost, these new meds have a lot going against them.
It was really helpful to have the medication cost information. Many times in my practice cost to my patient is heavily weighed when I'm considering medical treatments.
Dr. Yuhas was excellent!
Very clear and easy to follow presentation! Great CE!
Should have been 2 hours. Too much information for one hour!
Not sure if others noticed this, but for me, Dr. Yuhas froze several times or had words cut out during the presentation. Great speaker though and content was exactly what I needed! Thank you Thea and thank you Dr Yuhas!
I would treat glaucoma if I was younger but it sure was presented well!
Fantastic course!
Speaker could have used more time. Lots to cover!
Have this lecturer back. Too much repetition of lecturers.
Helpful review of preservative free Glaucoma medications.
It's great learning about an option without ocular inflammation to treat glaucoma.
Very cogent overview of the latest options. Solid presentation! Thank you!
Great talk. I took away a few good pearls!!
Speaker: Phillip Yuhas, OD
Moderator: Dr. Carolyn Majcher
COPE ID: 106418-GL
Category: Glaucoma
This event is COPE approved for 1 hour of CE credit.
Thank you to Thea for exhibiting at this event.
Established in 2019, Thea Pharma is the United States subsidiary of Laboratoires Théa, a global leader and pioneer in ophthalmics. We are committed to serve doctors that treat the anterior segment and ocular surface conditions.